levodopa has been researched along with Constipation in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.35) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 15 (65.22) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Della Morte, D; Geusa, L; Giannella, E; Grillo, P; Mascioli, D; Mercuri, NB; Sancesario, GM; Schirinzi, T; Zenuni, H | 1 |
| Espiritu, AI; Jamora, RDG; Pajo, AT | 1 |
| Fujita, H; Haruyama, Y; Hatano, T; Hattori, N; Hirano, S; Hirata, K; Kadowaki, T; Kaji, Y; Kobashi, G; Kuwabara, S; Miyamoto, M; Okuma, Y; Sakakibara, R; Shimo, Y; Suzuki, K; Uchiyama, T; Yamamoto, T | 1 |
| Stocchi, F; Torti, M | 1 |
| Cova, I; Priori, A | 1 |
| Daud, DB; McDonald, C | 1 |
| An, J; Chan, P; Gu, Z; Wang, C; Zhang, H | 1 |
| Garcia-Rubio, S; Giuliano, C; Karasawa, H; Pietra, C; Taché, Y; Wang, L; Xu, X; Yakabi, S | 1 |
| Bautista, A; Haider, JM; Pagano, G; Tagliati, M; Tan, EE | 1 |
| Barichella, M; Bolliri, C; Caronni, S; Cassani, E; Cereda, E; Faierman, SA; Ferri, V; Frazzitta, G; Iorio, L; Lignola, C; Lubisco, A; Monajemi, F; Pasqua, M; Petroni, ML; Pezzoli, G; Pinelli, G; Privitera, G; Pusani, C; Valentino, A | 1 |
| Hattori, N; Ohizumi, H; Tanaka, S; Yoritaka, A | 1 |
| Stiefelhagen, P | 1 |
| Kishi, M; Ogawa, E; Sakakibara, R; Takahashi, O; Tateno, F; Uchiyama, T; Yamamoto, T; Yamanishi, T; Yokoi, Y | 1 |
| Bloem, BR; Munneke, M; Petzinger, GM; Speelman, AD; van de Warrenburg, BP; van Nimwegen, M | 1 |
| Kishi, M; Ogawa, E; Sakakibara, R; Tateno, F | 1 |
| Budzianowska, A; Gołab-Janowska, M; Honczarenko, K | 1 |
| Li, M; Liu, Y; Yang, MH | 1 |
| Barichella, M; Caccialanza, R; Cancello, R; Cassani, E; Cereda, E; Iorio, L; Madio, C; Pezzoli, G; Pusani, C | 1 |
| Comella, CL; Janko, K; Morrissey, M | 1 |
| Ahlskog, JE | 1 |
| Krogh, K; Laurberg, S; Ostergaard, K; Sabroe, S | 1 |
| Misra, P | 1 |
| Astarloa, R; de la Vega, L; de Yébenes, JG; Mena, MA; Sánchez, V | 1 |
6 review(s) available for levodopa and Constipation
| Article | Year |
|---|---|
Efficacy and safety of extended-release amantadine in levodopa-induced dyskinesias: a meta-analysis.
Topics: Accidental Falls; Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Bias; Constipation; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome; Xerostomia | 2019 |
Constipation in Parkinson's Disease.
Topics: Antiparkinson Agents; Constipation; Gastrointestinal Microbiome; Gastrointestinal Motility; Humans; Levodopa; Parkinson Disease | 2017 |
Diagnostic biomarkers for Parkinson's disease at a glance: where are we?
Topics: alpha-Synuclein; Biomarkers; Brain; Cognition Disorders; Constipation; Depression; Early Diagnosis; Genetic Predisposition to Disease; Humans; Inflammation; Levodopa; Metabolomics; Microbiota; Movement Disorders; Neuroimaging; Olfaction Disorders; Parkinson Disease; REM Sleep Behavior Disorder; Symptom Assessment; Vision Disorders | 2018 |
Medical and surgical care for patients with Parkinson's disease.
Topics: Antiparkinson Agents; Catechol O-Methyltransferase Inhibitors; Constipation; Delirium; Dizziness; Dopamine Agonists; Hospitalization; Humans; Levodopa; Mobility Limitation; Monoamine Oxidase Inhibitors; Pain; Parkinson Disease | 2018 |
How might physical activity benefit patients with Parkinson disease?
Topics: Antiparkinson Agents; Cardiovascular Diseases; Cognition; Constipation; Depressive Disorder; Dopamine; Humans; Levodopa; Motor Activity; Muscle Fatigue; Osteoporosis; Parkinson Disease; Psychomotor Performance; Quality of Life; Sedentary Behavior; Sleep Wake Disorders | 2011 |
Beating a dead horse: dopamine and Parkinson disease.
Topics: Animals; Antiparkinson Agents; Brain; Brain Tissue Transplantation; Constipation; Deep Brain Stimulation; Dopamine; Humans; Levodopa; Olfaction Disorders; Parkinson Disease; REM Sleep Behavior Disorder | 2007 |
3 trial(s) available for levodopa and Constipation
| Article | Year |
|---|---|
Levodopa ameliorated anorectal constipation in de novo Parkinson's disease: The QL-GAT study.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Constipation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 2011 |
[Effects of "attenuation and synergia" for Bushenhuoxue Granules on Parkinson's patients].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antiparkinson Agents; Benserazide; Constipation; Double-Blind Method; Drug Combinations; Drugs, Chinese Herbal; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phytotherapy; Plants, Medicinal; Treatment Outcome; Urination Disorders | 2012 |
Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy.
Topics: Age Factors; Aged; Antiparkinson Agents; Brain; Circadian Rhythm; Constipation; Dizziness; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Pergolide; Placebos; Sex Factors; Sleep; Sleep Wake Disorders; Treatment Outcome | 2005 |
14 other study(ies) available for levodopa and Constipation
| Article | Year |
|---|---|
Constipation distinguishes different clinical-biochemical patterns in de novo Parkinson's disease.
Topics: alpha-Synuclein; Biomarkers; Constipation; Humans; Lactates; Levodopa; Parkinson Disease; Serum Albumin | 2022 |
Determinants of Low Body Mass Index in Patients with Parkinson's Disease: A Multicenter Case-Control Study.
Topics: Aged; Body Mass Index; Case-Control Studies; Constipation; Deglutition Disorders; Dopamine Agents; Dyskinesias; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index | 2020 |
Non-motor symptoms in treated and untreated Chinese patients with early Parkinson's disease.
Topics: Age Factors; Antiparkinson Agents; China; Cohort Studies; Constipation; Depression; Dopamine Agonists; Humans; Levodopa; Logistic Models; Parkinson Disease; Sex Factors; Sleep Wake Disorders; Time Factors | 2014 |
New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Brain; Constipation; Gastrointestinal Transit; Ghrelin; Immunohistochemistry; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley | 2014 |
Constipation is reduced by beta-blockers and increased by dopaminergic medications in Parkinson's disease.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Antiparkinson Agents; Cohort Studies; Constipation; Cross-Sectional Studies; Dopamine Agents; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Treatment Outcome | 2015 |
Dietary habits and neurological features of Parkinson's disease patients: Implications for practice.
Topics: Aged; Antiparkinson Agents; Case-Control Studies; Constipation; Cross-Sectional Studies; Diet, Healthy; Energy Intake; Feeding Behavior; Female; Food-Drug Interactions; Hospitals, Special; Humans; Italy; Levodopa; Male; Malnutrition; Middle Aged; Outpatient Clinics, Hospital; Parkinson Disease; Patient Compliance; Prevalence; Risk; Severity of Illness Index | 2017 |
Parkinson's disease with and without REM sleep behaviour disorder: are there any clinical differences?
Topics: Age Factors; Aged; Antiparkinson Agents; Brain; Brain Mapping; Constipation; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Logistic Models; Male; Odds Ratio; Parkinson Disease; REM Sleep Behavior Disorder; Sex Factors; Tomography, Emission-Computed, Single-Photon | 2009 |
[Dysphagia, constipation, impacted feces: Parkinson disease is also a gastrointestinal disease].
Topics: Antiparkinson Agents; Constipation; Deglutition Disorders; Fecal Impaction; Gastrointestinal Diseases; Humans; Levodopa; Parkinson Disease | 2010 |
Constipation triggered the malignant syndrome in Parkinson's disease.
Topics: Administration, Oral; Aged; Antiparkinson Agents; Constipation; Humans; Levodopa; Male; Panax; Parkinson Disease; Plant Extracts; Receptors, Serotonin, 5-HT3; Tomography, X-Ray Computed; Zanthoxylum; Zingiberaceae | 2012 |
[Autonomic disorders in Parkinson's disease].
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Causality; Comorbidity; Constipation; Deglutition Disorders; Erectile Dysfunction; Female; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Incidence; Levodopa; Male; Middle Aged; Nocturia; Parkinson Disease; Severity of Illness Index; Sex Distribution; Sialorrhea; Statistics, Nonparametric; Urinary Incontinence; Urologic Diseases; Vomiting | 2011 |
Nutritional risk and gastrointestinal dysautonomia symptoms in Parkinson's disease outpatients hospitalised on a scheduled basis.
Topics: Aged; Confidence Intervals; Constipation; Deglutition Disorders; Female; Gastrointestinal Diseases; Hospitalization; Humans; Levodopa; Male; Malnutrition; Middle Aged; Nutritional Status; Odds Ratio; Outpatients; Parkinson Disease; Prevalence; Primary Dysautonomias; Risk Factors; Severity of Illness Index; Sialorrhea; Weight Loss | 2013 |
Clinical aspects of bowel symptoms in Parkinson's disease.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Anal Canal; Antiparkinson Agents; Autonomic Pathways; Central Nervous System; Comorbidity; Constipation; Disability Evaluation; Disease Progression; Enteric Nervous System; Fecal Incontinence; Female; Humans; Intestines; Levodopa; Male; Middle Aged; Parkinson Disease; Prevalence; Surveys and Questionnaires | 2008 |
Hepatic encephalopathy.
Topics: Amino Acids; Ammonia; Bromocriptine; Constipation; Dietary Proteins; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hypnotics and Sedatives; Infections; Kidney Diseases; Lactulose; Levodopa; Liver Diseases; Neomycin; Neurotransmitter Agents | 1981 |
Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson disease.
Topics: Administration, Oral; Aged; Constipation; Dietary Fiber; Female; Gastrointestinal Motility; Humans; Intestinal Absorption; Levodopa; Male; Motor Activity; Movement Disorders; Parkinson Disease; Psychomotor Performance; Time Factors | 1992 |